Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Investor News Updates.
Press releases published on September 4, 2025
ServiceTitan Announces Strategic Partnership With Roto-Rooter
GlobeNewswire
·
September 4, 2025
LOS ANGELES, Sept. 04, 2025 (GLOBE NEWSWIRE) -- ServiceTitan (Nasdaq: TTAN), the software platform that powers the trades, today announced a strategic partnership with Roto-Rooter, the largest provider of plumbing, drain cleaning, and water cleanup …
ServiceTitan Announces Fiscal Second Quarter Financial Results
GlobeNewswire
·
September 4, 2025
LOS ANGELES, Sept. 04, 2025 (GLOBE NEWSWIRE) -- ServiceTitan (NASDAQ: TTAN), the software platform that powers the trades, today announced financial results for the fiscal second quarter ended July 31, 2025. “I am grateful for the way our team empowered …
Sportsman’s Warehouse Holdings, Inc. Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
September 4, 2025
Same store sales increased 2.1% over last year; outperforms the Q2 Adjusted NICS data Gross margin up 80 basis points versus last year Improves its full year 2025 Outlook WEST JORDAN, Utah, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Sportsman's Warehouse Holdings, …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 4, 2025
CONSHOHOCKEN, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
Cipher Mining Announces August 2025 Operational Update
GlobeNewswire
·
September 4, 2025
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ:CIFR) (“Cipher” or the “Company”) today released its unaudited production and operations update for August 2025. Key Highlights Key Metrics August 2025 BTC Mined1 241 BTC Sold 42 BTC …
Zumiez Inc. Announces Fiscal 2025 Second Quarter Results
GlobeNewswire
·
September 4, 2025
Second Quarter Comparable Sales Increased 2.5% North American Second Quarter Comparable Sales Increased 4.2% Third Quarter-to-date Comparable Sales up 11.2% LYNNWOOD, Wash., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Zumiez Inc. (NASDAQ: ZUMZ) a leading specialty …
Regeneron Announces Updated Presentation Time for Upcoming Investor Conference
GlobeNewswire
·
September 4, 2025
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will now present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 7:00 a.m. ET on Monday, September 8, 2025. The …
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2025
GlobeNewswire
·
September 4, 2025
SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its …
STRATA Skin Sciences Announces Closing of $2.42 Million Registered Direct Offering
GlobeNewswire
·
September 4, 2025
HORSHAM, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (Nasdaq: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of …
MARA Announces Bitcoin Production and Mining Operation Updates for August 2025
GlobeNewswire
·
September 4, 2025
208 Blocks Won in August Increased BTC Holdings* to 52,477 BTC Miami, FL, Sept. 04, 2025 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the "Company"), a leading digital energy and infrastructure company, today published unaudited …
Nasdaq CFO Sarah Youngwood to Present at Barclays Annual Global Financial Services Conference
GlobeNewswire
·
September 4, 2025
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conference, with a webcast available at Nasdaq’s Investor Relations website: ir.nasdaq.com/events.com. Who: Sarah Youngwood, Executive Vice …
CBL International Reports 1H 2025 Results Highlighting Strong Biofuel Growth, Reduced Net Loss, and Improved Gross Profit Margin
GlobeNewswire
·
September 4, 2025
Demonstrating Remarkable Resilience Amid a Challenging Macroeconomic Environment Kuala Lumpur, Sept. 04, 2025 (GLOBE NEWSWIRE) -- CBL International Limited (NASDAQ: BANL) (the “Company” or “CBL”), the listing vehicle of the Banle Group (“Banle” or “the …
Concrete Pumping Holdings Reports Third Quarter Fiscal Year 2025 Results
GlobeNewswire
·
September 4, 2025
DENVER, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the "Company" or "CPH"), a leading provider of concrete pumping and waste management services in the U.S. and U.K., reported financial results for the third quarter …
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
GlobeNewswire
·
September 4, 2025
Another addition to Amneal’s growing complex injectables portfolio reflects leadership in advanced development and manufacturing of complex pharmaceuticals BRIDGEWATER, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the …
Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
September 4, 2025
RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), …
Praxis Precision Medicines to Participate in September Investor Conferences
GlobeNewswire
·
September 4, 2025
BOSTON, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders …
Indaptus Therapeutics Provides Clinical Update
GlobeNewswire
·
September 4, 2025
Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases Decoy20 combination with PD-1 inhibitor, tislelizumab, demonstrates safety profiles consistent with each agent NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- …
Inventiva to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
September 4, 2025
Daix (France), New York City (New York, United States), September 4, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment …
Inventiva annonce sa participation à plusieurs conférences investisseurs en septembre
GlobeNewswire
·
September 4, 2025
Daix (France), New York City (New York, Etats-Unis), le 4 septembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de …
CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
September 4, 2025
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …